EDITORIAL |
*
Scleroderma renal crisis: are there any hopes for changes?
|
4-9 |
HOTLINE TOPIC |
*
Hantavirus-induced renal damage: a call for the nephrologist
|
10-14 |
*
Nephrotic crise
|
15-17 |
STATE-OF-ART |
S.R. Gilyarevsky
Hyperuricemia and chronic heart failure: is there any connection?
|
18-22 |
L.V. Kozlovskaya
Focal segmental glomerulosclerosis: focus on cyclosporine
|
23-28 |
HOTLINE TOPIC |
M.A. Shestakova, S.A. Martynov
Anaemia correction in diabetic nephropathy: target haemoglobin values and cardiovascular complications
|
29-33 |
ORIGINAL PAPERS |
A.A. Demin, V.A. Kozlov, I.A. Lisukov, T.N. Sentiakova, A.D. Kulagin, E.V. Malyh, I.V. Kriuchkova, A.E. Sizikov, S.A. Sizikova, L.P. Konenkova, O.A. Gertsog, V.V. Sergeevicheva, M.N. Afonkina, O.S. Kotova
High-dose immunosupressive therapy and stev haemopoetic cell tranplantation in refractory systemic lupus erythematosus with kidney involvement: long-term results
|
34-40 |
M.M. Batiushin, N.S, Vrublevskaya, V.P. Terentiev
Prognostic determinants of chronic heart failure, complicated with renal disfunction
|
41-44 |
E.A. Saginova, A.D. Aksiutin, T.N. Krasnova, V.V. Fomin, N.A. Moukhin
Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight
|
45-49 |
L.V. Podorolskaya, E.L. Tchumakova, L.V. Lobanova, L.A. Alexeeva
Fibrinolytic activity of the urine in patients with arterial hypertension with different efficacy of antihypertensive treatment
|
50-52 |
M.L. Maximov
Angiotensin II receptor blocker valsartan and angiotensin-converting enzyme inhibitor enalapril in hypertensive patients with renal transpalant nephropathy
|
53-56 |
PERSPECTIVE IN NEPHROLOGY |
I.A. Bondar, V.V. Klimontov
Intracellular signalling pathways in diabetic nephropathy: new targets for nephroprotection
|
57-63 |
PHARMACOTHERAPY |
V.V. Fomin, V.V. Panasiuk
Frequent pitfalls in antihypertensive therapy
|
64-69 |
NEPHROLOGICAL FORUM |
V.V. Fomin, A.A. Pulin, V.V. Rameev, V.P. Sedov, A.D. Meshkov, S.V. Roschupkina, V.V. Panasiuk, L.V. Kozlovskaya, N.A. Moukhin
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
|
70-78 |
EPONYM |
*
Bowman capsule
|
79-80 |